3-hydroxyflavone has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, X; Guo, L; Luo, Q; Tan, K | 1 |
| Chen, F; Ma, Y; Sun, Z; Zhu, X | 1 |
| Ge, C; Gu, T; Hu, L; Li, Q; Lou, D; Nie, X; Qin, Y; Tan, J; Wang, M; Xu, M | 1 |
| Fu, FH; Jiang, WL; Li, GS; Qu, GW; Tian, JW; Wu, J; Yue, XD | 1 |
4 other study(ies) available for 3-hydroxyflavone and Diabetic Nephropathies
| Article | Year |
|---|---|
Dihydromyricetin promotes autophagy and attenuates renal interstitial fibrosis by regulating miR-155-5p/PTEN signaling in diabetic nephropathy.
Topics: Animals; Autophagy; Cells, Cultured; Diabetic Nephropathies; Disease Models, Animal; Flavonols; MicroRNAs; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Signal Transduction; Transfection | 2020 |
Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Proteins; Cell Line; Cell Survival; Cytoprotection; Diabetic Nephropathies; Dose-Response Relationship, Drug; Epithelial Cells; Flavonols; Glucose; Humans; Kidney Tubules, Proximal; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation.
Topics: Animals; Diabetic Nephropathies; Diet, High-Fat; Flavonoids; Flavonols; Forkhead Box Protein O1; Hepatitis A Virus Cellular Receptor 1; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Receptor-Interacting Protein Serine-Threonine Kinases | 2019 |
Effect of astilbin on experimental diabetic nephropathy in vivo and in vitro.
Topics: Animals; Antioxidants; Body Weight; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavonols; Glucose; Humans; Kidney; Longevity; Male; Models, Animal; Phytotherapy; Plant Extracts; Random Allocation; Rats; Rats, Sprague-Dawley; Rhizome; Smilax; Transforming Growth Factor beta1 | 2009 |